Zelda Therapeutics enters medical cannabis research partnership

2017-12-08 09:23:00
The halt will remain in place until Tuesday 12th December 2017.
The company's shares are in pre-open

Zelda Therapeutics Ltd (ASX:ZLD) continues to advance its medical cannabis strategy, and the company entered a trading halt this morning pending details of a partnership with a US-based research institution.

READ: Zelda approved for Australia’s first medicinal cannabis trial targeting insomnia

The halt will remain in place until the opening of trade on Tuesday 12th December 2017, or earlier if an announcement is made to the market.